Gene therapy with adeno-associated viral (AAV) vectors is limited by AAV cargo capacity that prevents their application to the inherited retinal diseases (IRDs), such as Stargardt disease (STGD) or Usher syndrome type IB (USH1B), which are due to mutations in genes larger than 5 kb. Trans-splicing or hybrid dual AAV vectors have been successfully exploited to reconstitute large gene expression in the mouse retina. Here, we tested them in the large cone-enriched pig retina that closely mimics the human retina. We found that dual AAV trans-splicing and hybrid vectors transduce pig photoreceptors, the major cell targets for treatment of IRDs, to levels that were about two-to threefold lower than those obtained with a single AAV vector of normal size. This efficiency is significantly higher than that in mice, and is potentially due to the high levels of dual AAV co-transduction we observe in pigs. We also show that subretinal delivery in pigs of dual AAV trans-splicing and hybrid vectors successfully reconstitute, albeit at variable levels, the expression of the large genes ABCA4 and MYO7A mutated in STGD and USH1B, respectively. Our data support the potential of dual AAV vectors for large gene reconstitution in the cone-enriched pig retina that is a relevant preclinical model.
INTRODUCTION
Inherited retinal diseases (IRDs) cause untreatable blindness in about 1 out of 2000 people worldwide. 1 IRDs are mostly monogenic and are caused by mutations in genes mainly expressed in retinal photoreceptors (rods and cones; PRs) and to a lesser extent in the retinal pigment epithelium (RPE). [2] [3] Gene therapy with adeno-associated viral (AAV) vectors represents, to date, the most promising approach to prevent PR degeneration in IRDs. Indeed, AAVs: (1) delivered subretinally have been shown to be safe and effective in patients with Leber congenital amaurosis type 2, a severe form of inherited childhood blindness; 4-9 and (2) are to date the only available gene therapy vectors that efficiently deliver genes to PRs in addition to RPE in small and large animal models. [10] [11] [12] [13] [14] [15] [16] However, the relatively small DNA packaging capacity of AAV vectors, which is considered to be restricted to the size of the parental genome (4.7 kb), [17] [18] [19] [20] prevents its application from the treatment of those forms of IRD caused by mutations in genes having a coding sequence (CDS) 45 kb (herein referred to as large genes). Among them there are: Stargardt disease (STGD; MIM#248200) that is the most common form of inherited macular degeneration caused by mutations in the PR-specific ABCA4 gene (ATP-binding cassette subfamily A member 4, CDS: 6822 bp); 21 and Usher syndrome type IB (USH1B; MIM#276900) that is the most severe form of retinitis pigmentosa associated with deafness and that is caused by mutations in the MYO7A gene (MYOSIN VII A, CDS: 6648 bp) 22 that is expressed in both PRs and RPE in the retina. [23] [24] [25] [26] To date, two strategies have been developed to overcome AAV limited-cargo capacity: oversize AAV vectors [27] [28] [29] [30] and dual AAV vectors. [31] [32] [33] [34] Oversize AAV vectors are produced by 'forcing' the packaging of large genes flanked by AAV inverted terminal repeats, into AAV capsids. [27] [28] [29] [30] 35 Although we and others have shown that delivery of oversize vectors results in significant therapeutic efficacy in both rodent and canine models of human inherited diseases, 29, [36] [37] [38] the development of this vector platform for clinical applications is prevented by the heterogeneity of the genomes contained in oversize AAV capsids that represents a major safety concern. [18] [19] [20] 30, 35, [39] [40] On the other hand, dual AAV vectors are generated by splitting a large transgene expression cassette in two separate halves each packaged in a single normal size (NS; o5 kb) AAV vector. [31] [32] 34, 41 The reconstitution of the full-length expression cassette is achieved upon coinfection of the same cell by both dual AAV vectors followed by one of the following: ITR-mediated tail-to-head concatemerization of the 5 0 and 3 0 genomes followed by splicing (dual AAV trans-splicing vectors); [31] [32] [33] 42 homologous recombination between overlapping regions contained in 5 0 and 3 0 genomes (dual AAV overlapping vectors); 32 or a combination of the two (dual AAV hybrid vectors). 34 The defined nature of the genomes contained in dual AAV vectors makes them the favored AAV-based platform to treat IRDs caused by mutations in large genes. We have recently shown the potential of dual AAV vectors in the retina: we have found that both dual AAV trans-splicing (TS) and hybrid AK vectors (that contain a short recombinogenic region from the F1 phage) transduce efficiently mouse PRs and RPE, and rescue mouse models of STGD and USH1B. 43 These data support further development of these platforms that should include testing their efficiency in the retina of a large, clinically relevant animal model, which has not been performed so far. This is particularly important as the efficiency of gene reconstitution by dual AAVs may vary significantly in diverse species as it depends on complex and still largely unknown DNA repair mechanisms. 35, [44] [45] Herein, we investigated the efficiency of dual AAV TS and hybrid AK vectors, in which gene reconstitution should occur independently of the transgene sequence, in the retina of large white (LW) pigs that is an excellent model of the human retina as it has a similar size and architecture, and is enriched with cones that are concentrated in a streak-like region where their density is comparable to that of the primate macula. 11, [46] [47] [48] [49] [50] In particular, we evaluated dual AAV TS and hybrid AK ability to transduce both pig PRs and RPE using either the EGFP reporter or the large therapeutic ABCA4 and MYO7A genes. Our results showed that subretinal delivery of both dual AAV vector platforms resulted in transgene reconstitution in both pig PRs and RPE to levels that in PRs were around a fourth of those we had achieved with a single AAV vector in the case of EGFP. These data strongly indicate that these strategies could be feasible for the treatment of IRDs such as STGD and USH1B caused by mutations in large genes.
RESULTS AND DISCUSSION
In this study, we used either single NS, dual AAV trans-splicing (TS) or hybrid AK vectors that encode EGFP. 43 In addition, we used dual AAV vectors that included the CDS of the therapeutic ABCA4 and MYO7A genes, tagged with 3xflag and hemoagglutinin (HA), respectively, 43 to distinguish the exogenous protein products from the endogenous products expressed in the LW pig retina. We did not include dual AAV overlapping vectors because we have previously shown that they are inefficient at transducing both mouse and pig PRs. 43 The constructs used for the production of the various AAV vectors are listed in Supplementary Table S1 and a schematic representation of the various approaches is depicted in Supplementary Figure S1 . To deliver the genes to the retina, we used AAV2/8 vectors, which efficiently transduce both pig RPE and PRs, [10] [11] [12] and either ubiquitous (chicken beta actin or cytomegalovirus (CMV)), or PR-specific rhodopsin (RHO) promoters 11 (Supplementary Table S1 ). To evaluate the transduction of pig PRs and RPE by dual AAV TS and hybrid AK vectors and to compare it with that of AAV NS, we initially used EGFP as this is the only transgene among those we selected for this study that fits into AAV NS. We used the 1:1 ratio of 5 0 and 3 0 halves of dual AAV vectors as we had previously found that this was the optimal ratio in the mouse retina. 43 The LW pigs were injected subretinally with a total dose of 2 Â 10 11 genome copies (GC)/eye (dose of each vector/eye: 1 Â 10 11 GC), which was similar to the highest AAV dose (1.5 Â 10 11 GC/eye) that was shown to be well tolerated and effective in Leber congenital amaurosis type 2 patients. 7 When using AAV NS, we injected 1 Â 10 11 GC/eye subretinally as this would correspond to the same amount of full size large genomes obtained if all dual AAV vectors administered would undergo a productive tail-to-head concatemerization. Thus, LW pigs were injected subretinally with AAV NS, AAV TS or hybrid AK vectors encoding EGFP under the transcriptional control of either the ubiquitous CMV or the PRspecific RHO promoter (Figure 1 and Supplementary Figure S2) . Fluorescence microscope analysis of retinal cryosections 1 month after injection showed that EGFP was robustly expressed in a large area of the pig retina whether treated with AAV NS or with any of the dual AAV vector platforms ( Figure 1 and Supplementary Figure  S2 ). Remarkably, we showed that dual AAV TS and hybrid AK vectors produced high levels of EGFP in both pig PRs and RPE although these levels appeared lower than those achieved with AAV NS. These results confirmed previous findings in mice. Dual AAV in the pig retina P Colella et al
As most IRDs are due to mutations in genes expressed in PRs, 3 efficient gene delivery to PRs is crucial for successful gene therapy of IRDs. Indeed, the efficiency of PR transduction positively correlates with therapeutic efficacy in preclinical studies. [51] [52] Therefore, we quantified the specific PR transduction efficiency of dual AAV TS and hybrid AK vectors compared with that of AAV NS. To do this objectively, we measured by enzyme-linked immunosorbent assay (ELISA) the levels of EGFP in pig retina lysates 1 month after subretinal delivery of either AAV NS or dual AAV TS and hybrid AK vectors all encoding for EGFP under the control of the PR-specific RHO promoter (Figure 2a) . We found that the levels of EGFP expression in pig PRs with dual AAV TS and hybrid AK vectors were on average about 2.5-fold lower than with single AAV NS. Notably, a similar experiment in the mouse retina showed that dual AAV vectors reconstituted EGFP expression at levels on average 25-fold lower than AAV NS. 43 We investigated whether this could be due to higher rate in pigs than in mice of combined 5'-and 3'-half vector transduction of the same cell following subretinal injection of dual AAV vectors. To do so, we injected subretinally in LW pigs a mixture of AAV2/8-CMV-EGFP and -RFP vectors (dose of each vector/eye: 1 Â 10 11 GC/eye) and analyzed PR co-transduction on retinal cryosections 6 weeks after injection (Figure 2b ). Interestingly, we found that in the pig retina, the percentage of transduced PRs that expressed both EGFP and red fluorescent protein (RFP) was 73 ± 5% as opposed to the 24 ± 2% that we had previously observed in mice. 43 This may explain the higher efficiency of photoreceptor gene expression observed in pig than in the mouse retina following subretinal delivery of dual AAV TS and AK vectors.
Finally, taking advantage of the high cone/rod ratio of the pig retina, 46 we compared cone transduction by dual AAV vectors with the one achieved with AAV NS (Figure 3 and Supplementary Figure S3 ). To do this, we performed immunofluorescence analyses with anti-human cone-arrestin (hCAR) antibodies on retinal cryosections from pigs treated with either AAV NS or dual AAV vectors both encoding EGFP under the control of the CMV promoter that, differently from the RHO promoter, drives transgene expression in both pig rod and cone PRs.
11
Colocalization of EGFP expression with hCAR staining by confocal microscopy analysis showed that the number of cones transduced by dual AAV TS and hybrid AK vectors was similar to that transduced by AAV NS, despite the EGFP intensity/cell was lower with dual AAV than with AAV NS vectors ( Figure 3 and Supplementary Figure S3 ). In conclusion, the efficiency of dual AAV TS and hybrid AK vectors supports their use for large gene therapy to pig rods, cones and RPE. EGFP allows to easily localize and quantify transgene expression within the retina; however, the size of EGFP CDS is significantly shorter than that of ABCA4 (CDS: 6822 bp) or MYO7A (CDS: 6648 bp). In addition, the transgene sequence may influence the efficacy of large gene reconstitution even when it is not directly taking part in AAV genome intermolecular rejoining, as in case of dual AAV TS and hybrid AK vectors. Thus, we evaluated the expression of the large ABCA4 and MYO7A genes in the pig retina after subretinal delivery of either dual AAV TS or hybrid AK vectors. As ABCA4 is expressed specifically in PRs, 21 we injected subretinally in LW pigs dual AAV TS and hybrid AK vectors (dose of each vector/eye: 1 Â 10 11 GC) encoding ABCA4-3xflag under the control of the RHO promoter. One month later, we analyzed the retinal lysates by western blot using anti3xflag antibodies (Figure 4a ). Both dual AAV approaches induced the expression of the full-length ABCA4-3xflag protein in PRs, although at variable levels ( Figure 4a ). Interestingly, dual AAV hybrid AK vectors resulted in more consistent ABCA4 expression compared with dual AAV TS vectors (Figure 4a) , similar to what we had previously observed in mice. 43 Unlike ABCA4, MYO7A
needs to be expressed in both PRs and RPE, [23] [24] [25] [26] therefore the MYO7A-HA gene contained in dual AAV TS and hybrid AK vectors was under the transcriptional control of the ubiquitous chicken beta actin promoter. [10] [11] One month after subretinal delivery of dual AAV vectors (dose of each vector/eye: 1 Â 10 11 GC) in LW pigs, we evaluated the expression of MYO7A-HA in both retina and RPE lysates by western blot analysis with anti-HA antibodies (Figure 4b ). The analysis showed that the levels of MYO7A expression achieved in the RPE and retina with either of the dual AAV approaches were similar (Figure 4b) . By using anti-Myo7a antibodies, we recently found that the levels of MYO7A obtained after subretinal delivery of dual AAV TS and hybrid AK vectors in shaker1 À / À mice are about 20% of endogenous. 43 Differently from shaker1 À / À mice, LW pigs express endogenous MYO7A protein that is strongly recognized by anti-Myo7a antibodies in the RPE (data not shown). This prevented us from comparing the levels of MYO7A from dual AAV vectors with the pig endogenous MYO7A levels as we did in mice. In conclusion, we confirmed that both dual AAV-based TS and hybrid AK platforms resulted in expression of the large ABCA4 and MYO7A proteins involved in STGD and USH1B, respectively. In the case of ABCA4, the efficiency of the dual AAV hybrid AK system appeared superior to that of dual AAV TS, although a precise quantification based on larger number of injected pig eyes would be required to ultimately define this.
We have previously reported that production of protein products shorter than expected occurs in vitro but not in the retina of mice following administration of either the combination or the single 5 0 and 3 0 half vectors of dual AAV TS and hybrid AK platforms. 43 These short products presumably derive from single 5 0 and 3 0 halves that did not undergo productive reassembly, 43 although we cannot exclude that they derive from rearrangements such as incorrect splicing. In the current study, we confirm that no protein products shorter than full size ABCA4 or MYO7A are found by western blot analysis of pig retinal lysates using antibodies directed against the 3xflag and HA tags present in the 3 0 vector (data not shown). Additional studies in pigs with transgenes tagged at the 5 0 -end will be required to exclude the presence of truncated proteins from the 5 0 -half vectors, as we did in mouse retina. 43 Finally, future formal toxicity studies will properly address the safety of dual AAV vectors in the pig retina.
Overall, our data support the use of both dual AAV platforms, and preferably dual AAV hybrid AK vectors for transfer of large therapeutic genes to the pig retina and for future gene therapy of inherited blinding conditions like STGD and USH1B.
MATERIALS AND METHODS

Generation of AAV vector plasmids
The plasmids used for AAV vector production were derived from either the pZac2.1 or pAAV2.1 plasmids that contained the inverted terminal repeats of AAV serotype 2 (Supplementary Table S1 ). NS AAV vector plasmids contained full-length expression cassettes including the promoter, the fulllength transgene CDS and the poly-adenylation signal (Supplementary  Table S1 ). Two separate AAV vector plasmids (5 0 and 3 0 ) were required to generate dual AAV vectors and contained either the promoter followed by the N-terminal portion of the transgene CDS (5 0 plasmid) or the C-terminal portion of the transgene CDS followed by the polyA signal (3 0 plasmid, Supplementary Table S1 ). The constructs used in this study had been previously reported by our group. 43 The details of cloning strategies as well as plasmid sequences are available upon request.
AAV vector production AAV vectors were produced by the TIGEM AAV Vector Core by triple transfection of HEK293 cells followed by two rounds of CsCl2 purification. 53 For each viral preparation, physical titers (GC ml À 1 ) were determined by averaging the titer achieved by dot-blot analysis 54 and by PCR quantification using TaqMan 53 (Applied Biosystems, Carlsbad, CA, USA). 21-5-12) . All surgeries were performed under anesthesia and all efforts were made to minimize suffering. Twelve-week-old LW female pigs were obtained from the Azienda Agricola Pasotti (Imola, Italy) and registered as purebred in the LWHerd Book of the Italian National Pig Breeders' Association.
Subretinal delivery of AAV vectors to the pig retina was performed in 12-week-old pigs as previously described.
11 All eyes were treated with 100 ml of AAV2/8 vector solution. The AAV2/8 dose was 1 Â 10 11 GC of each vector/eye and co-injection of dual AAV vectors resulted in a total dose of 2 Â 10 11 GC/eye. Eyes were harvested 1-1.5 months after subretinal AAV injection.
Western blot analysis and ELISA Pig samples (the treated areas of the retina as well as whole RPE sheets) were lysed in radioimmunoprecipitation assay buffer (50 mM Tris-HCl, pH 8.0, 150 mM NaCl, 1% NP40, 0.5% Na-deoxycholate, 1mM EDTA, pH 8.0, 0.1% SDS) to extract MYO7A from RPE sheets and in SIE buffer (250 mM sucrose, 3 mM imidazole, pH 7.4, 1% ethanol and 1% NP40) to extract MYO7A and ABCA4 from retinas. Lysis buffers were supplemented with protease inhibitors (Complete Protease inhibitor cocktail tablets, Roche, Milan, Italy) and 1 mM phenylmethylsulfonyl. After lysis, EGFP and MYO7A samples were denatured at 99 1C for 5 min in 1 Â laemli sample buffer; ABCA4 samples were denatured at 37 1C (Figure 4a ). The densitometric quantifications were performed using ImageJ software (http://rsb.info.nih.gov/ij/). The ELISA was performed on whole pig retina lysates using the Max Discovery Green Fluorescent Protein Kit ELISA (Bioo Scientific Corporation, Austin, TX, USA).
Histological analyses
To evaluate EGFP expression in histological sections (Figures 1, 2b, 3 and Supplementary Figures S2 and S3 ), eyes were enucleated, fixed in 4% paraformaldehyde for 48 h, infiltrated with 10% sucrose for 4 h, 20% sucrose for 12 h and finally 30% sucrose overnight. Then, the cornea, the lens and the vitreous body were dissected and the EGFP-positive portions of the eyecups were embedded in optimal cutting temperature compound (O.C.T. matrix, Kaltek, Padua, Italy). Serial cryosections (12 mm thick) were cut along the horizontal meridian and progressively distributed on slides. The analysis of EGFP fluorescence and image acquisition were performed using a Leica microscope (Leica Application Suite v. 2.3.6 DM6000B, Leica Microsystems, Milan, Italy). PR co-transduction following subretinal combined delivery of AAV2/8-CMV-EGFP and -RFP vectors has been evaluated as follows: pictures of retinal cryosections from n ¼ 3 eyes were captured under a fluorescence microscope using either the fluorescein isothiocyanate (FITC) (to visualize EGFP þ cells) or rhodamine (to visualize RFP þ cells) filters. For each eye RFP þ PRs (at least 200) contained in about three independent sections per eye and the corresponding EGFP þ PRs were counted at Â 10 magnification. PRs expressing both EGFP and RFP were unequivocally identified based on their identical shape on picture micrographs of the same field taken under either the FITC or rhodamine filter. To calculate the percentage of cotransduced PRs, the number of PR expressing both EGFP and RFP was divided by the total number of transduced PRs, that is, PRs expressing at least one of the two reporter genes.
Anti-hCAR immunofluorescence and confocal microscopy analysis
To evaluate cone transduction in retinas injected with AAV vectors encoding for EGFP (Figure 3 and Supplementary Figure S3) , OCT cryosections were immunostained with an anti-human cone arrestin antibodies (anti-hCAR, kindly provided by Cheryl M Craft, University of Southern California, Los Angeles, CA, USA 55 ) as follows: cryosections were progressively washed once in phosphate-buffered saline (PBS) for 5 min, permeabilized in PBS-0.2% Triton X-100 for 1 h, incubated in blocking solution containing 10% normal donkey serum (Sigma-Aldrich, St Louis, MO, USA) for 1 h, incubated with primary antibody rabbit anti-hCAR (diluted 1:10 000 in PBS) overnight at 4 1C, washed three times for 5 min with PBS, incubated with secondary antibody (anti-rabbit Alexa Fluor 594; 1:1000; Molecular Probes, Invitrogen, Carlsbad, CA, USA) for 1 h at room temperature, washed three times with PBS for 10 min and finally mounted with Vectashield (Vector Lab Inc, Peterborough, UK). EGFP and hCAR colocalization was evaluated by confocal microscopy using a Laser Scanning Microscope LSM710 v.5.0 SP1.1, Zen 2008 Software (Carl Zeiss, Microimaging, Germany) as we had previously described. 48 Briefly, for each eye, we took pictures of retinal sections stained with anti-CAR antibodies and then analyzed the single planes (Z-stacks) of each picture. To count EGFP þ cones, we first identified the CAR þ cells in the section (by looking at CAR and DAPI staining) and then we evaluated which cell was also EGFP þ (EGFP þ CAR þ ). In doing this, we carefully moved along the Z-axis to distinguish one cell from another and thus to avoid to count twice the same cell. For each eye a minimum of B150 hCAR þ cells were analyzed for EGFP expression. The analysis was performed in regions in which the EGFP fluorescence was most intense.
Statistical analysis
Data are presented as mean ± s.e.m. Statistical P-values o0.05 were considered significant. One-way analysis of variance (ANOVA) with post-hoc multiple comparison procedure was used to compare data depicted in Figure 2a 
